Embed this press release by copying the code below:
CEL-SCI Corporation Announces IDMC Conclusions from Interim Review of Phase III Head and Neck Cancer Trial Data
CEL-SCI Corporation Announces IDMC Conclusions from Interim Review of Phase III Head and Neck Cancer Trial Data